Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
•
Osteomyelitis
•
Osteoarticular infection
Which dosing strategy do you typically use for dalbavancin for staph aureus vertebral osteomyelitis?
Related Questions
For how long would you treat a patient with dematiaceous fungi growing on a native heart valve discovered at the time of valve replacement?
Do you approach suppressive antibiotic therapy differently for patients with cardiac implant- able electronic devices infections compared to patients with LVAD related infections?
What factors do you consider when choosing between baloxavir and oseltamivir for treating patients with influenza?
Do you treat complicated pneumonia with a drained empyema longer if Streptococcus anginosus is cultured, either in isolation or with other organisms, compared to cases in which it is not?
When would you consider long-term suppressive antibiotic therapy in patients with chronic or recurrent bacterial prostatitis who continue to experience symptoms despite multiple courses of antibiotics?
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
Do you recommend treating Candida albicans on urine culture from an indwelling catheter in a patient with septic shock?
Do you routinely use oral vancomycin prophylaxis in patients with a history of CDI who are receiving antibiotics?
Do you routinely recommend suppressive antibiotic therapy for patients with spinal hardware infections who have undergone surgical debridement with retention of hardware?
What are your top takeaways from IDWeek 2025?
